Treatment of amyotrophic lateral sclerosis (ALS)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11931375
APP PUB NO 20220211744A1
SERIAL NO

17701238

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and delivery methods for the treatment of spinal cord related disorders including ALS.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VOYAGER THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Carroll, Soper Jenna Winchester, US 7 10
Chen, Qingmin Belmont, US 23 174
Patzke, Holger Cambridge, US 17 26
Sah, Dinah Wen-Yee Hopkinton, US 80 756

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 19, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 19, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 19, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00